Ali Behbahani, 10% Owner at Trevi Therapeutics, Inc. (TRVI), sold 564 shares at $2.66 ($2K) on 2020-04-03, disclosed to the SEC on 2020-04-13.
Open-market sale of $2k TRVI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADAP | SELL | 2025-08-19 | $342K | — | Filing → |
| MBX | BUY | 2024-09-17 | $8.0M | — | Filing → |
| SVRA | BUY | 2023-07-19 | $1000K | — | Filing → |